Her.9 will be a revolutionary DTC brand to look after the holistic needs of a woman during pregnancy. The prenatal supplements market will be worth $56 billion by 2025. Her.9 will utilise first mover advantage in Europe with our DUOCAP technology and globally with our probiotic pairing.
Other food services
|Date||Amount||No. of Investors|
|HALLER, Maximilian Daniel George||Director||20/04/2020||Swiss|
|PORPORA, Henry Carmine Franco||Director||20/04/2020||British|
|SHARMA, Rajinder Kumar||Director||20/06/2020||British|